n,n-dimethylarginine has been researched along with cyclin d1 in 1 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, RQ; Fang, HR; Hu, B; Li, YJ; Ren, YK; Tang, XQ; Wang, CY; Zhou, CF | 1 |
1 other study(ies) available for n,n-dimethylarginine and cyclin d1
| Article | Year |
|---|---|
Endogenous hydrogen sulfide is involved in asymmetric dimethylarginine-induced protection against neurotoxicity of 1-methyl-4-phenyl-pyridinium ion.
Topics: 1-Methyl-4-phenylpyridinium; Aminooxyacetic Acid; Animals; Antioxidants; Arginine; Cyclin D1; Cystathionine beta-Synthase; Cytochromes c; Down-Regulation; Hydrogen Sulfide; Membrane Potential, Mitochondrial; Neuroprotective Agents; PC12 Cells; Rats; Reactive Oxygen Species | 2011 |